LONDON, October 2, 2017 /PRNewswire/ --
Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease
The Global Treatment for Neglected Tropical Disease market is expected to grow at a CAGR of 7.3% in the second half of the forecast period. The Global Treatment for Neglected Tropical Disease market reached $1.5bn in 2016, dominated by the treatments for malaria which held 30% share of the market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 157-page report you will receive 71 tables and 80 figures- all unavailable elsewhere.
The 157-page report provides clear detailed insight into the Global Treatment for Neglected Tropical Disease market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
• Global Treatment for Neglected Tropical Disease market forecasts from 2017-2027
• This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by disease type:
- Malaria treatments
- Dengue treatments
- Lymphatic Filariasis
- Chagas Disease
For each disease type, the report provides a SWOT analysis, a list of selected drugs and revenue forecasts from 2017-2027 of the leading drugs.
• This report provides revenue forecast for these leading drugs:
- Coartem (Novartis)
- Clindamycin (Pfizer)
- Dengvaxia (Sanofi)
- AmBisome (Gilead Sciences)
- Impavido (Knight Therapeutics)
- ALBENZA (Amedra Pharmaceuticals LLC)
• This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by regional and national market:
- North America: US and Canada
- Europe: Germany, the UK, France, Spain, Italy, Rest of Europe
- Asia-Pacific: Japan, China, India, Rest of Asia
- Latin America: Brazil, Mexico, Rest of Latin America
- Middle East & Africa: Saudi Arabia, South of Africa, Rest of Middle East & Africa
Each regional market is further broken down by disease type.
• This report provides company overview, financial information, product portfolio and recent developments for the leading companies in the neglected tropical disease market:
- Pfizer, Inc.
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Novartis International AG
- Takeda Pharmaceutical Company Ltd
- Sanofi S.A.
- Eisai Co., Ltd
Buy our report today Global Treatment for Neglected Tropical Disease Market 2017-2027: Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease.
To request a report overview of this report please email Sara Peerun at email@example.com or call Tel: +44-(0)-20-7336-6100
List of Companies Mentioned in The Report
Amedra Pharmaceuticals LLC
APP Pharmaceuticals LLC
Asian Development Bank
Eisai Co., Ltd
F. Hoffmann-La Roche AG
Johnson & Johnson
Kadmon Pharmaceuticals LLC
Nicholas Piramal India Ltd.
Novartis International AG
Takeda Pharmaceutical Company Ltd
To see a report overview please email Sara Peerun on firstname.lastname@example.org
SOURCE Visiongain Ltd